Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 320

1.

Identification of drug-specific public TCR driving severe cutaneous adverse reactions.

Pan RY, Chu MT, Wang CW, Lee YS, Lemonnier F, Michels AW, Schutte R, Ostrov DA, Chen CB, Phillips EJ, Mallal SA, Mockenhaupt M, Bellón T, Tassaneeyakul W, White KD, Roujeau JC, Chung WH, Hung SI.

Nat Commun. 2019 Aug 8;10(1):3569. doi: 10.1038/s41467-019-11396-2.

2.

Sustained Progression-Free Survival Benefit of Rituximab Maintenance in Patients With Follicular Lymphoma: Long-Term Results of the PRIMA Study.

Bachy E, Seymour JF, Feugier P, Offner F, López-Guillermo A, Belada D, Xerri L, Catalano JV, Brice P, Lemonnier F, Martin A, Casasnovas O, Pedersen LM, Dorvaux V, Simpson D, Leppa S, Gabarre J, da Silva MG, Glaisner S, Ysebaert L, Vekhoff A, Intragumtornchai T, Le Gouill S, Lister A, Estell JA, Milone G, Sonet A, Farhi J, Zeuner H, Tilly H, Salles G.

J Clin Oncol. 2019 Jul 24:JCO1901073. doi: 10.1200/JCO.19.01073. [Epub ahead of print]

PMID:
31339826
3.

Evaluating CD8+ T Cell Responses In Vitro.

Lemonnier FA.

Methods Mol Biol. 2019;1988:199-215. doi: 10.1007/978-1-4939-9450-2_15.

PMID:
31147942
4.

The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations.

Steinhilber J, Mederake M, Bonzheim I, Serinsöz-Linke E, Müller I, Fallier-Becker P, Lemonnier F, Gaulard P, Fend F, Quintanilla-Martinez L.

Mod Pathol. 2019 Jul;32(8):1123-1134. doi: 10.1038/s41379-019-0254-4. Epub 2019 Apr 5.

PMID:
30952970
5.

Induction of tumor-specific CTL responses using the C-terminal fragment of Viral protein R as cell penetrating peptide.

Gross DA, Leborgne C, Chappert P, Masurier C, Leboeuf M, Monteilhet V, Boutin S, Lemonnier FA, Davoust J, Kichler A.

Sci Rep. 2019 Mar 8;9(1):3937. doi: 10.1038/s41598-019-40594-7.

6.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d'Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J.

Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19.

PMID:
30782609
7.

Human preprocalcitonin self-antigen generates TAP-dependent and -independent epitopes triggering optimised T-cell responses toward immune-escaped tumours.

Durgeau A, Virk Y, Gros G, Voilin E, Corgnac S, Djenidi F, Salmon J, Adam J, de Montpréville V, Validire P, Ferrone S, Chouaib S, Eggermont A, Soria JC, Lemonnier F, Tartour E, Chaput N, Besse B, Mami-Chouaib F.

Nat Commun. 2018 Nov 30;9(1):5097. doi: 10.1038/s41467-018-07603-1.

8.

Treatment with 5-azacytidine induces a sustained response in patients with angioimmunoblastic T-cell lymphoma.

Lemonnier F, Dupuis J, Sujobert P, Tournillhac O, Cheminant M, Sarkozy C, Pelletier L, Marçais A, Robe C, Fataccioli V, Haioun C, Hermine O, Gaulard P, Delarue R.

Blood. 2018 Nov 22;132(21):2305-2309. doi: 10.1182/blood-2018-04-840538. Epub 2018 Oct 2. No abstract available.

PMID:
30279227
9.

New insights in the pathogenesis of T-cell lymphomas.

Lemonnier F, Gaulard P, de Leval L.

Curr Opin Oncol. 2018 Sep;30(5):277-284. doi: 10.1097/CCO.0000000000000474. Review.

PMID:
30028743
10.

Multiple Ways to Detect IDH2 Mutations in Angioimmunoblastic T-Cell Lymphoma from Immunohistochemistry to Next-Generation Sequencing.

Dupuy A, Lemonnier F, Fataccioli V, Martin-Garcia N, Robe C, Pelletier R, Poullot E, Moktefi A, Mokhtari K, Rousselet MC, Traverse-Glehen A, Delarue R, Tournilhac O, Delfau-Larue MH, Haioun C, Ortonne N, Copie-Bergman C, de Leval L, Pujals A, Gaulard P.

J Mol Diagn. 2018 Sep;20(5):677-685. doi: 10.1016/j.jmoldx.2018.05.012. Epub 2018 Jul 5.

PMID:
29981867
11.

Humanized Mouse Model to Study Type 1 Diabetes.

Luce S, Guinoiseau S, Gadault A, Letourneur F, Blondeau B, Nitschke P, Pasmant E, Vidaud M, Lemonnier F, Boitard C.

Diabetes. 2018 Sep;67(9):1816-1829. doi: 10.2337/db18-0202. Epub 2018 Jul 2.

12.

Home spirometry in bronchiolitis obliterans after allogeneic haematopoietic cell transplant.

Loiseau C, Lemonnier F, Randrianarivelo O, Itzykson R, Nguyen S, Becquemin MH, Tcherakian C, Uzunov M, Catherinot E, Rivaud E, Salvator H, Devillier P, Sutton L, Vernant JP, Couderc LJ, Dhédin N.

Eur Respir J. 2018 Jul 19;52(1). pii: 1702328. doi: 10.1183/13993003.02328-2017. Print 2018 Jul. No abstract available.

PMID:
29794130
13.

RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.

Vallois D, Dupuy A, Lemonnier F, Allen G, Missiaglia E, Fataccioli V, Ortonne N, Clavert A, Delarue R, Rousselet MC, Fabiani B, Llamas-Gutierrez F, Ogawa S, Thome M, Ko YH, Kataoka K, Gaulard P, de Leval L.

Haematologica. 2018 Aug;103(8):e360-e363. doi: 10.3324/haematol.2017.186767. Epub 2018 Mar 15. No abstract available.

14.

Loss of 5-hydroxymethylcytosine is a frequent event in peripheral T-cell lymphomas.

Lemonnier F, Poullot E, Dupuy A, Couronné L, Martin N, Scourzic L, Fataccioli V, Bruneau J, Cairns RA, Mak TW, Bernard OA, de Leval L, Gaulard P.

Haematologica. 2018 Mar;103(3):e115-e118. doi: 10.3324/haematol.2017.167973. Epub 2017 Dec 14. No abstract available.

15.

Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K protein.

Lorente E, Barriga A, García-Arriaza J, Lemonnier FA, Esteban M, López D.

PLoS Negl Trop Dis. 2017 Oct 30;11(10):e0006036. doi: 10.1371/journal.pntd.0006036. eCollection 2017 Oct.

16.

Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring.

Scheikl-Gatard T, Tosch C, Lemonnier F, Rooke R.

J Transl Med. 2017 Jul 5;15(1):154. doi: 10.1186/s12967-017-1254-0.

17.

Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells.

Lemonnier F, Mak TW.

J Pathol. 2017 Aug;242(4):387-390. doi: 10.1002/path.4920. Epub 2017 Jun 29.

PMID:
28543514
18.

Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.

Dobay MP, Lemonnier F, Missiaglia E, Bastard C, Vallois D, Jais JP, Scourzic L, Dupuy A, Fataccioli V, Pujals A, Parrens M, Le Bras F, Rousset T, Picquenot JM, Martin N, Haioun C, Delarue R, Bernard OA, Delorenzi M, de Leval L, Gaulard P.

Haematologica. 2017 Apr;102(4):e148-e151. doi: 10.3324/haematol.2016.158428. Epub 2017 Jan 12. No abstract available.

19.

The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development.

Lemonnier F, Cairns RA, Inoue S, Li WY, Dupuy A, Broutin S, Martin N, Fataccioli V, Pelletier R, Wakeham A, Snow BE, de Leval L, Pujals A, Haioun C, Paci A, Tobin ER, Narayanaswamy R, Yen K, Jin S, Gaulard P, Mak TW.

Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):15084-15089. doi: 10.1073/pnas.1617929114. Epub 2016 Dec 12.

20.

Activating TCR Signaling to Thwart T-ALL.

Lemonnier F, Mak TW.

Cancer Discov. 2016 Sep;6(9):946-8. doi: 10.1158/2159-8290.CD-16-0789.

21.

Genomic Classification in Acute Myeloid Leukemia.

Lemonnier F, Inoue S, Mak TW.

N Engl J Med. 2016 Sep 1;375(9):900. doi: 10.1056/NEJMc1608739. No abstract available.

PMID:
27579652
22.

Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2.

Inoue S, Li WY, Tseng A, Beerman I, Elia AJ, Bendall SC, Lemonnier F, Kron KJ, Cescon DW, Hao Z, Lind EF, Takayama N, Planello AC, Shen SY, Shih AH, Larsen DM, Li Q, Snow BE, Wakeham A, Haight J, Gorrini C, Bassi C, Thu KL, Murakami K, Elford AR, Ueda T, Straley K, Yen KE, Melino G, Cimmino L, Aifantis I, Levine RL, De Carvalho DD, Lupien M, Rossi DJ, Nolan GP, Cairns RA, Mak TW.

Cancer Cell. 2016 Aug 8;30(2):337-348. doi: 10.1016/j.ccell.2016.05.018. Epub 2016 Jul 14.

23.

Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.

Vallois D, Dobay MP, Morin RD, Lemonnier F, Missiaglia E, Juilland M, Iwaszkiewicz J, Fataccioli V, Bisig B, Roberti A, Grewal J, Bruneau J, Fabiani B, Martin A, Bonnet C, Michielin O, Jais JP, Figeac M, Bernard OA, Delorenzi M, Haioun C, Tournilhac O, Thome M, Gascoyne RD, Gaulard P, de Leval L.

Blood. 2016 Sep 15;128(11):1490-502. doi: 10.1182/blood-2016-02-698977. Epub 2016 Jul 1.

24.

Response to 5-azacytidine in a patient with TET2-mutated angioimmunoblastic T-cell lymphoma and chronic myelomonocytic leukaemia preceded by an EBV-positive large B-cell lymphoma.

Saillard C, Guermouche H, Derrieux C, Bruneau J, Frenzel L, Couronne L, Asnafi V, Macintyre E, Trinquand A, Lhermitte L, Molina T, Suarez F, Lemonnier F, Kosmider O, Delarue R, Hermine O, Cheminant M.

Hematol Oncol. 2017 Dec;35(4):864-868. doi: 10.1002/hon.2319. Epub 2016 Jun 29.

PMID:
27353473
25.

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.

Jardin F, Pujals A, Pelletier L, Bohers E, Camus V, Mareschal S, Dubois S, Sola B, Ochmann M, Lemonnier F, Viailly PJ, Bertrand P, Maingonnat C, Traverse-Glehen A, Gaulard P, Damotte D, Delarue R, Haioun C, Argueta C, Landesman Y, Salles G, Jais JP, Figeac M, Copie-Bergman C, Molina TJ, Picquenot JM, Cornic M, Fest T, Milpied N, Lemasle E, Stamatoullas A, Moeller P, Dyer MJ, Sundstrom C, Bastard C, Tilly H, Leroy K.

Am J Hematol. 2016 Sep;91(9):923-30. doi: 10.1002/ajh.24451. Epub 2016 Jul 4.

26.

Roles of IDH1/2 and TET2 mutations in myeloid disorders.

Inoue S, Lemonnier F, Mak TW.

Int J Hematol. 2016 Jun;103(6):627-33. doi: 10.1007/s12185-016-1973-7. Epub 2016 Mar 15. Review.

PMID:
26980223
27.

Fractionated elution using the TEKCIS technetium-99m generator.

Vigne J, De Mil R, Peyronnet D, Hecquard C, Agostini D, Lemonnier F.

Nucl Med Commun. 2016 Jun;37(6):664-8. doi: 10.1097/MNM.0000000000000499.

PMID:
26945284
28.

Optimizing hepatitis B vaccination in prison.

Perrodeau F, Pillot-Debelleix M, Vergniol J, Lemonnier F, Receveur MC, Trimoulet P, Raymond I, Le Port G, Gromb-Monnoyeur S.

Med Mal Infect. 2016 Mar;46(2):96-9. doi: 10.1016/j.medmal.2016.01.002. Epub 2016 Feb 19.

PMID:
26905392
29.

Idh1 mutations contribute to the development of T-cell malignancies in genetically engineered mice.

Hao Z, Cairns RA, Inoue S, Li WY, Sheng Y, Lemonnier F, Wakeham A, Snow BE, Dominguez-Brauer C, Ye J, Larsen DM, Straley KS, Tobin ER, Narayanaswamy R, Gaulard P, Mak TW.

Proc Natl Acad Sci U S A. 2016 Feb 2;113(5):1387-92. doi: 10.1073/pnas.1525354113. Epub 2016 Jan 19.

30.

The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.

Johnstone C, Lorente E, Barriga A, Barnea E, Infantes S, Lemonnier FA, David CS, Admon A, López D.

Mol Cell Proteomics. 2015 Apr;14(4):893-904. doi: 10.1074/mcp.M114.045401. Epub 2015 Jan 29.

31.

Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.

Cheminant M, Bruneau J, Kosmider O, Lefrere F, Delarue R, Gaulard P, Radford I, Derrieux C, Hermine O, Lemonnier F.

Br J Haematol. 2015 Mar;168(6):913-6. doi: 10.1111/bjh.13170. Epub 2014 Oct 14. No abstract available.

PMID:
25312805
32.

Uncovering the peptide-binding specificities of HLA-C: a general strategy to determine the specificity of any MHC class I molecule.

Rasmussen M, Harndahl M, Stryhn A, Boucherma R, Nielsen LL, Lemonnier FA, Nielsen M, Buus S.

J Immunol. 2014 Nov 15;193(10):4790-802. doi: 10.4049/jimmunol.1401689. Epub 2014 Oct 13.

33.

Associations of HLA-A, HLA-B and HLA-C alleles frequency with prevalence of herpes simplex virus infections and diseases across global populations: implication for the development of an universal CD8+ T-cell epitope-based vaccine.

Samandary S, Kridane-Miledi H, Sandoval JS, Choudhury Z, Langa-Vives F, Spencer D, Chentoufi AA, Lemonnier FA, BenMohamed L.

Hum Immunol. 2014 Aug;75(8):715-29. doi: 10.1016/j.humimm.2014.04.016. Epub 2014 May 4.

34.

Neuropilin-1 expression characterizes T follicular helper (Tfh) cells activated during B cell differentiation in human secondary lymphoid organs.

Renand A, Milpied P, Rossignol J, Bruneau J, Lemonnier F, Dussiot M, Coulon S, Hermine O.

PLoS One. 2013 Dec 30;8(12):e85589. doi: 10.1371/journal.pone.0085589. eCollection 2013.

35.

Identification of conserved and HLA promiscuous DENV3 T-cell epitopes.

Nascimento EJ, Mailliard RB, Khan AM, Sidney J, Sette A, Guzman N, Paulaitis M, de Melo AB, Cordeiro MT, Gil LV, Lemonnier F, Rinaldo C, August JT, Marques ET Jr.

PLoS Negl Trop Dis. 2013 Oct 10;7(10):e2497. doi: 10.1371/journal.pntd.0002497. eCollection 2013.

36.

The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.

Luce S, Briet C, Bécourt C, Lemonnier F, Boitard C.

Diabetes Obes Metab. 2013 Sep;15 Suppl 3:89-97. doi: 10.1111/dom.12159. Review.

PMID:
24003925
37.

HLA-A*01:03, HLA-A*24:02, HLA-B*08:01, HLA-B*27:05, HLA-B*35:01, HLA-B*44:02, and HLA-C*07:01 monochain transgenic/H-2 class I null mice: novel versatile preclinical models of human T cell responses.

Boucherma R, Kridane-Miledi H, Bouziat R, Rasmussen M, Gatard T, Langa-Vives F, Lemercier B, Lim A, Bérard M, Benmohamed L, Buus S, Rooke R, Lemonnier FA.

J Immunol. 2013 Jul 15;191(2):583-93. doi: 10.4049/jimmunol.1300483. Epub 2013 Jun 17.

38.

Cloning CD8⁺ cytolytic T lymphocytes.

Lemonnier FA.

Methods Mol Biol. 2013;960:279-296. doi: 10.1007/978-1-62703-218-6_21.

PMID:
23329494
39.

Evaluating CD8⁺ T cell responses in vitro.

Lemonnier FA.

Methods Mol Biol. 2013;960:261-277. doi: 10.1007/978-1-62703-218-6_20.

PMID:
23329493
40.

HLA-B7-restricted islet epitopes are differentially recognized in type 1 diabetic children and adults and form weak peptide-HLA complexes.

Scotto M, Afonso G, Østerbye T, Larger E, Luce S, Raverdy C, Novelli G, Bruno G, Gonfroy-Leymarie C, Launay O, Lemonnier FA, Buus S, Carel JC, Boitard C, Mallone R.

Diabetes. 2012 Oct;61(10):2546-55.

41.

Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.

Lemonnier F, Couronné L, Parrens M, Jaïs JP, Travert M, Lamant L, Tournillac O, Rousset T, Fabiani B, Cairns RA, Mak T, Bastard C, Bernard OA, de Leval L, Gaulard P.

Blood. 2012 Aug 16;120(7):1466-9. doi: 10.1182/blood-2012-02-408542. Epub 2012 Jul 3.

42.

West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands.

Jung KO, Khan AM, Tan BY, Hu Y, Simon GG, Nascimento EJ, Lemonnier F, Brusic V, Miotto O, Tan TW, Marques ET, Dhalia R, Salmon J, August JT.

J Virol. 2012 Jul;86(14):7616-24. doi: 10.1128/JVI.00166-12. Epub 2012 May 9.

43.

Loss of central and peripheral CD8+ T-cell tolerance to HFE in mouse models of human familial hemochromatosis.

Boucherma R, Kridane-Miledi H, Vives FL, Vauchy C, Borg C, Kleinclauss F, Fiette L, Tiberghien P, Lemonnier FA, Rohrlich PS, Huetz F.

Eur J Immunol. 2012 Apr;42(4):851-62. doi: 10.1002/eji.201141664.

44.

Zinc transporter (ZnT)8(186-194) is an immunodominant CD8+ T cell epitope in HLA-A2+ type 1 diabetic patients.

Scotto M, Afonso G, Larger E, Raverdy C, Lemonnier FA, Carel JC, Dubois-Laforgue D, Baz B, Levy D, Gautier JF, Launay O, Bruno G, Boitard C, Sechi LA, Hutton JC, Davidson HW, Mallone R.

Diabetologia. 2012 Jul;55(7):2026-31. doi: 10.1007/s00125-012-2543-z. Epub 2012 Apr 20.

45.

Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT.

Lemonnier F, Rivaud E, Neveu H, Catherinot E, Suarez F, Dhedin N, Couderc LJ.

Bone Marrow Transplant. 2012 Oct;47(10):1374. doi: 10.1038/bmt.2012.23. Epub 2012 Feb 27. No abstract available.

PMID:
22367343
46.

Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.

Lorente E, García R, Mir C, Barriga A, Lemonnier FA, Ramos M, López D.

J Biol Chem. 2012 Mar 23;287(13):9990-10000. doi: 10.1074/jbc.M111.314856. Epub 2012 Feb 1.

47.

IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma.

Cairns RA, Iqbal J, Lemonnier F, Kucuk C, de Leval L, Jais JP, Parrens M, Martin A, Xerri L, Brousset P, Chan LC, Chan WC, Gaulard P, Mak TW.

Blood. 2012 Feb 23;119(8):1901-3. doi: 10.1182/blood-2011-11-391748. Epub 2012 Jan 3.

48.

Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells.

Lorente E, Infantes S, Barnea E, Beer I, García R, Lasala F, Jiménez M, Vilches C, Lemonnier FA, Admon A, López D.

J Virol. 2012 Jan;86(1):527-41. doi: 10.1128/JVI.05737-11. Epub 2011 Oct 26.

49.

Single insulin-specific CD8+ T cells show characteristic gene expression profiles in human type 1 diabetes.

Luce S, Lemonnier F, Briand JP, Coste J, Lahlou N, Muller S, Larger E, Rocha B, Mallone R, Boitard C.

Diabetes. 2011 Dec;60(12):3289-99. doi: 10.2337/db11-0270. Epub 2011 Oct 13.

50.

[Bronchiolitis obliterans postallogeneic stem cell transplantation: what is new?].

Lemonnier F, Dhedin N, Catherinot E, Tcherakian C, Neveu H, Suarez F, Becquemin MH, Devillier P, Vernant JP, Couderc LJ, Rivaud E.

Rev Pneumol Clin. 2011 Sep;67(4):258-66. doi: 10.1016/j.pneumo.2011.06.003. Epub 2011 Aug 6. Review. French.

PMID:
21920287

Supplemental Content

Loading ...
Support Center